metricas
covid
Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Diabetic ketoacidosis associated to canagliflozin in type 2 diabetes
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
Diabetic ketoacidosis associated to canagliflozin in type 2 diabetes
Cetoacidosis diabética asociada a canagliflozina en diabetes mellitus tipo 2
Silvia González Sanchidrián
Corresponding author
silvia_goz@hotmail.com

Corresponding author.
, Juan Ramón Gómez-Martino Arroyo, Pedro Jesús Labrador Gómez
Servicio de Nefrología, Hospital San Pedro de Alcántara, Complejo Hospitalario de Cáceres, Cáceres, Spain
Read
254
Times
was read the article
3
Total PDF
251
Total HTML
Share statistics
 array:24 [
  "pii" => "S2387020617300189"
  "issn" => "23870206"
  "doi" => "10.1016/j.medcle.2017.01.016"
  "estado" => "S300"
  "fechaPublicacion" => "2017-02-23"
  "aid" => "3863"
  "copyright" => "Elsevier España, S.L.U.. All rights reserved"
  "copyrightAnyo" => "2016"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "cor"
  "cita" => "Med Clin. 2017;148:e19-20"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S002577531630608X"
      "issn" => "00257753"
      "doi" => "10.1016/j.medcli.2016.11.016"
      "estado" => "S300"
      "fechaPublicacion" => "2017-02-23"
      "aid" => "3863"
      "copyright" => "Elsevier España, S.L.U."
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "cor"
      "cita" => "Med Clin. 2017;148:e19-20"
      "abierto" => array:3 [
        "ES" => false
        "ES2" => false
        "LATM" => false
      ]
      "gratuito" => false
      "lecturas" => array:2 [
        "total" => 30
        "formatos" => array:2 [
          "HTML" => 24
          "PDF" => 6
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>"
        "titulo" => "Cetoacidosis diab&#233;tica asociada a canagliflozina en diabetes mellitus tipo 2"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "e19"
            "paginaFinal" => "e20"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Diabetic ketoacidosis associated to canagliflozin in type 2 diabetes"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Silvia Gonz&#225;lez Sanchidri&#225;n, Juan Ram&#243;n G&#243;mez-Martino Arroyo, Pedro Jes&#250;s Labrador G&#243;mez"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "Silvia"
                "apellidos" => "Gonz&#225;lez Sanchidri&#225;n"
              ]
              1 => array:2 [
                "nombre" => "Juan Ram&#243;n"
                "apellidos" => "G&#243;mez-Martino Arroyo"
              ]
              2 => array:2 [
                "nombre" => "Pedro Jes&#250;s"
                "apellidos" => "Labrador G&#243;mez"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2387020617300189"
          "doi" => "10.1016/j.medcle.2017.01.016"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020617300189?idApp=UINPBA00004N"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S002577531630608X?idApp=UINPBA00004N"
      "url" => "/00257753/0000014800000004/v1_201702040018/S002577531630608X/v1_201702040018/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2387020617301304"
    "issn" => "23870206"
    "doi" => "10.1016/j.medcle.2017.02.017"
    "estado" => "S300"
    "fechaPublicacion" => "2017-02-23"
    "aid" => "3864"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46;"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "cor"
    "cita" => "Med Clin. 2017;148:e21-2"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
      "titulo" => "Diagnosis of myocardial abscess secondary to infective endocarditis <span class="elsevierStyleSup">18</span>F-fluorodeoxyglucose positron emission tomography"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "e21"
          "paginaFinal" => "e22"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Diagn&#243;stico de absceso mioc&#225;rdico por endocarditis infecciosa mediante tomograf&#237;a de emisi&#243;n de positrones con <span class="elsevierStyleSup">18</span>F-fluorodesoxiglucosa"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1895
              "Ancho" => 900
              "Tamanyo" => 140355
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleSup">18</span>FDG positron emission tomography showing a well-defined area of increased glycolytic activity in the outflow tract of the left ventricle&#44; indicating the presence of an intramyocardial abscess &#40;marked with an arrow&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Jos&#233; L&#243;pez-Aguilera, Amador L&#243;pez-Granados, Dolores Mesa-Rubio"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Jos&#233;"
              "apellidos" => "L&#243;pez-Aguilera"
            ]
            1 => array:2 [
              "nombre" => "Amador"
              "apellidos" => "L&#243;pez-Granados"
            ]
            2 => array:2 [
              "nombre" => "Dolores"
              "apellidos" => "Mesa-Rubio"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0025775316306091"
        "doi" => "10.1016/j.medcli.2016.11.017"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775316306091?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020617301304?idApp=UINPBA00004N"
    "url" => "/23870206/0000014800000004/v1_201703290102/S2387020617301304/v1_201703290102/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2387020617301298"
    "issn" => "23870206"
    "doi" => "10.1016/j.medcle.2016.11.036"
    "estado" => "S300"
    "fechaPublicacion" => "2017-02-23"
    "aid" => "3859"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46;"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "cor"
    "cita" => "Med Clin. 2017;148:192-3"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
      "titulo" => "Family medicine in the training of the doctors of the future&#44; and nowadays"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "192"
          "paginaFinal" => "193"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Medicina de familia en la formaci&#243;n del m&#233;dico del futuro&#44; y del presente"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Esteban Gonz&#225;lez L&#243;pez, Maria Isabel Garc&#237;a L&#225;zaro, Angel Otero Puime"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Esteban"
              "apellidos" => "Gonz&#225;lez L&#243;pez"
            ]
            1 => array:2 [
              "nombre" => "Maria Isabel"
              "apellidos" => "Garc&#237;a L&#225;zaro"
            ]
            2 => array:2 [
              "nombre" => "Angel"
              "apellidos" => "Otero Puime"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0025775316306042"
        "doi" => "10.1016/j.medcli.2016.11.012"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775316306042?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020617301298?idApp=UINPBA00004N"
    "url" => "/23870206/0000014800000004/v1_201703290102/S2387020617301298/v1_201703290102/en/main.assets"
  ]
  "en" => array:13 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
    "titulo" => "Diabetic ketoacidosis associated to canagliflozin in type 2 diabetes"
    "tieneTextoCompleto" => true
    "saludo" => "Dear Editor&#44;"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "e19"
        "paginaFinal" => "e20"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Silvia Gonz&#225;lez Sanchidri&#225;n, Juan Ram&#243;n G&#243;mez-Martino Arroyo, Pedro Jes&#250;s Labrador G&#243;mez"
        "autores" => array:3 [
          0 => array:4 [
            "nombre" => "Silvia"
            "apellidos" => "Gonz&#225;lez Sanchidri&#225;n"
            "email" => array:1 [
              0 => "silvia&#95;goz&#64;hotmail&#46;com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "Juan Ram&#243;n"
            "apellidos" => "G&#243;mez-Martino Arroyo"
          ]
          2 => array:2 [
            "nombre" => "Pedro Jes&#250;s"
            "apellidos" => "Labrador G&#243;mez"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Nefrolog&#237;a&#44; Hospital San Pedro de Alc&#225;ntara&#44; Complejo Hospitalario de C&#225;ceres&#44; C&#225;ceres&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Cetoacidosis diab&#233;tica asociada a canagliflozina en diabetes mellitus tipo 2"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">In May 2015&#44; the US Food and Drug Administration&#44; and later&#44; its European and Spanish counterparts&#44; warned of the risk of diabetic ketoacidosis &#40;DKA&#41; associated with the use of canagliflozin&#44; dapagliflozin and empagliflozina&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Sodium-glucose cotransporter-2 inhibitors &#40;SGLT2-I&#41; are oral antidiabetic drugs &#40;OAD&#41; indicated in the treatment of diabetes mellitus &#40;DM&#41; 2&#44; alone or in combination with insulin or other hypoglycaemic drugs&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">We present a case of DKA associated with canagliflozin in a 39 year-old man diagnosed with type 2 DM from 29&#44; with a history of obesity&#44; hypertriglyceridemia&#44; smoking and poor metabolic control &#40;glycosylated haemoglobin &#91;HbA1c&#93; 12&#37;&#41;&#44; without associated vascular complications&#46; The patient had been treated with insulin&#44; which suspended due to poor tolerance&#44; and was currently in treatment with exenatide 2<span class="elsevierStyleHsp" style=""></span>mg&#47;week and canagliflozin 100<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#46; A week after the start of treatment with canagliflozin the patient came to the emergency room due to general malaise&#44; fatigue and vomiting&#46; He was conscious and oriented&#44; afebrile&#44; normally hydrated and well perfused but with significant malaise&#44; tachycardia and tachypnea&#44; with BP 143&#47;92<span class="elsevierStyleHsp" style=""></span>mmHg&#46; Neurological examination was normal&#46; Blood tests showed glycaemia 252<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&#44; severe metabolic acidosis &#40;pH 6&#46;98&#44; <span class="elsevierStyleItalic">p</span>CO<span class="elsevierStyleInf">2</span> 28<span class="elsevierStyleHsp" style=""></span>mmHg&#44; HCO<span class="elsevierStyleInf">3</span><span class="elsevierStyleSup">&#8722;</span> 6&#46;6<span class="elsevierStyleHsp" style=""></span>mEq&#47;l&#41;&#44; lactate<span class="elsevierStyleHsp" style=""></span>1&#46;9<span class="elsevierStyleHsp" style=""></span>mmol&#47;l and elevated anion gap &#40;40<span class="elsevierStyleHsp" style=""></span>mEq&#47;l&#41;&#59; urine glucose &#62;1000<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&#44; impaired kidney function &#40;urea 34<span class="elsevierStyleHsp" style=""></span>mg&#47;dl and creatinine 1&#46;22<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&#41; and mild hyponatremia &#40;132<span class="elsevierStyleHsp" style=""></span>mmol&#47;l&#41; with normal serum potassium&#46; In the blood count&#44; he showed mild leukocytosis &#40;13&#44;900 leukocytes&#44; 85&#37; neutrophils&#41; without elevated acute phase reactants or signs of infection&#46; Liver function tests and amylase and lipase levels were within the normal range&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">Suspecting severe DKA&#44;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> intensive fluid therapy&#44; bicarbonate infusion and intravenous insulin therapy was initiated&#46; The patient denied use of toxic substances and osmole hiatus &#60;20<span class="elsevierStyleHsp" style=""></span>mOsm&#47;l reasonably ruled out a metabolic acidosis secondary to alcohol poisoning&#46; C-peptide levels were normal &#40;2<span class="elsevierStyleHsp" style=""></span>ng&#47;ml&#41;&#46; Positive ketonuria &#40;80<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&#41; and ketonemia &#40;&#946; hydroxybutyrate 6&#46;5<span class="elsevierStyleHsp" style=""></span>mmol&#47;l&#41; supported the diagnosis of DKA&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">The patient required hospitalization&#46; Hyperglycaemia and ketonemia were quickly corrected&#59; metabolic acidosis persisted&#44; but was corrected within the first 48<span class="elsevierStyleHsp" style=""></span>h&#46; The patient improved and was discharged at 72<span class="elsevierStyleHsp" style=""></span>h with insulin treatment&#59; OAD treatment was discontinued&#46; Immunologic study was performed and the antibodies were negative&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">SGLT2-I act in the kidney on the SGLT2 cotransporter&#44; responsible for most glucose reabsorption in the renal tubules&#44; so its inhibition increases urinary glucose excretion and reduces plasma concentrations&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> Due to its mechanism of action&#44; the most common side effects are urinary tract infections and genital fungal infections&#44; osmotic diuresis and volume depletion&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> However&#44; the most serious side effect is DKA&#46;<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">3&#8211;5</span></a> Most cases have occurred in diabetics treated with insufficient insulin dose&#44; latent autoimmune diabetes in adults &#40;LADA&#41; or DM type 1&#44; although the European Medicines Agency reported 101 cases of DKA in patients with DM type 2&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> The incidence reported by Peters et al&#46;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a> was 5&#46;1&#8211;9&#46;4&#37; in DM type 1 treated with insulin and canagliflozin&#44; while the one reported by Erondu et al&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a> was 0&#46;07&#37; in DM type 2&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">The kidney plays a key role in the regulation of blood glucose and ketone bodies in the body&#44;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> but the exact mechanisms by which these OAD induce DKA are still unknown&#46; DKA induced by SGLT2-I usually occurs with low glucose levels &#40;&#60;250<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&#41; due to increased renal losses caused by these drugs&#44; with the decrease of available glucose as an energy substrate being the main causal mechanism&#46; Decreased renal elimination of ketone bodies by tubular reabsorption is also involved in the genesis&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> Precipitating factors are basically metabolic stress situations&#44; dehydration&#44; alcohol consumption or low-carbohydrate diets&#46;<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">3&#44;4</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">DKA induced by SGLT2-I is a rare but serious complication that can go unnoticed due to its presentation &#40;with non-excessively high blood glucose levels&#41;&#46; If the condition is suspected&#44; ketonemia determination is recommended for proper diagnosis and treatment&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> The patient should also be informed about risk situations that may precipitate the condition&#44; requiring a temporary discontinuation of treatment&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a></p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Gonz&#225;lez Sanchidri&#225;n S&#44; G&#243;mez-Martino Arroyo JR&#44; Labrador G&#243;mez PJ&#46; Cetoacidosis diab&#233;tica asociada a canagliflozina en diabetes mellitus tipo 2&#46; Med Clin &#40;Barc&#41;&#46; 2017&#59;148&#58;e19&#8211;e20&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Food and Drug Administration&#46; FDA drug safety communication&#58; FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too mucha cid in the blood &#91;online&#93;&#59; 2015&#46; Available from&#58; <a href="http://www.fda.gov/Drugs/DrugsSafety/ucm446845.htm">http&#58;&#47;&#47;www&#46;fda&#46;gov&#47;Drugs&#47;DrugsSafety&#47;ucm446845&#46;htm</a> &#91;accessed 19&#46;04&#46;15&#93;"
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "SGLT-2 inhibitors and their potential in the treatment of diabetes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "R&#46;F&#46; Rosenwasser"
                            1 => "S&#46; Sultan"
                            2 => "D&#46; Sutton"
                            3 => "R&#46; Choksi"
                            4 => "B&#46;J&#46; Epstein"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2147/DMSO.S34416"
                      "Revista" => array:6 [
                        "tituloSerie" => "Diabetes Metab Syndr Obes"
                        "fecha" => "2013"
                        "volumen" => "6"
                        "paginaInicial" => "453"
                        "paginaFinal" => "467"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24348059"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "American Association of Clinical Endocrinologist and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "Y&#46; Handelsman"
                            1 => "R&#46;R&#46; Henry"
                            2 => "Z&#46;T&#46; Bloomgarden"
                            3 => "S&#46; Dagogo-Jack"
                            4 => "R&#46;A&#46; DeFronzo"
                            5 => "D&#46; Einhom"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.4158/EP161292.PS"
                      "Revista" => array:6 [
                        "tituloSerie" => "Endocr Pract"
                        "fecha" => "2016"
                        "volumen" => "22"
                        "paginaInicial" => "753"
                        "paginaFinal" => "762"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27082665"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Diabetic ketoacidosis with canagliflozin&#44; a sodium-glucose cotransporter 2 inhibitor&#44; in patients with type 1 diabetes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46;L&#46; Peters"
                            1 => "R&#46;R&#46; Henry"
                            2 => "P&#46; Thakkar"
                            3 => "C&#46; Tong"
                            4 => "M&#46; Alba"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2337/dc15-1995"
                      "Revista" => array:6 [
                        "tituloSerie" => "Diabetes Care"
                        "fecha" => "2016"
                        "volumen" => "39"
                        "paginaInicial" => "532"
                        "paginaFinal" => "538"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26989182"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Diabetic ketoacidosis and related events in the canagliflozin type 2 diabetes clinical program"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "N&#46; Erondu"
                            1 => "M&#46; Desai"
                            2 => "K&#46; Ways"
                            3 => "G&#46; Meininger"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2337/dc15-1251"
                      "Revista" => array:6 [
                        "tituloSerie" => "Diabetes Care"
                        "fecha" => "2015"
                        "volumen" => "38"
                        "paginaInicial" => "1680"
                        "paginaFinal" => "1686"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26203064"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/23870206/0000014800000004/v1_201703290102/S2387020617300189/v1_201703290102/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "43309"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Letters to the Editor"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/23870206/0000014800000004/v1_201703290102/S2387020617300189/v1_201703290102/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020617300189?idApp=UINPBA00004N"
]
Article information
ISSN: 23870206
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 October 1 1 2
2024 September 7 0 7
2024 August 7 0 7
2024 July 3 0 3
2024 June 5 0 5
2024 May 1 0 1
2024 April 54 0 54
2024 March 1 0 1
2024 February 6 0 6
2024 January 10 0 10
2023 December 40 0 40
2023 November 11 1 12
2023 October 28 1 29
2023 September 11 0 11
2023 August 7 0 7
2023 July 10 0 10
2023 June 11 0 11
2023 May 1 0 1
2023 March 3 0 3
2023 January 1 0 1
2022 December 2 0 2
2022 November 2 0 2
2022 October 2 0 2
2022 September 15 0 15
2022 August 3 0 3
2022 July 2 0 2
2022 June 2 0 2
2022 May 1 0 1
2022 April 2 0 2
2022 March 2 0 2
Show all

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos